Stay updated on Tau Vaccine Safety in Early Alzheimer's Clinical Trial

Sign up to get notified when there's something new on the Tau Vaccine Safety in Early Alzheimer's Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tau Vaccine Safety in Early Alzheimer's Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details related to evaluating the safety, tolerability, and immunogenicity of Tau targeted vaccines in participants with early Alzheimer's Disease.
    Difference
    0.1%
    Check dated 2024-06-06T14:17:37.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria,' providing examples such as general health condition or prior treatments. Additionally, detailed eligibility criteria for the study have been specified, including age range, cognitive impairment status, and other health-related conditions.
    Difference
    48%
    Check dated 2024-05-22T20:56:47.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:47:43.000Z thumbnail image

Stay in the know with updates to Tau Vaccine Safety in Early Alzheimer's Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tau Vaccine Safety in Early Alzheimer's Clinical Trial page.